Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2
Status:
Unknown status
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the interest of maintenance treatment with
interleukin-2 by randomizing the patients being not allogeneic transplanted in complete
remission after induction and consolidation chemotherapy concerning the event free survival.